A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population

被引：0
|
作者：
Jennifer Jewell
Joshua Black
Matthew Ellis
Heather Olsen
Janetta Iwanicki
Richard Dart
机构：
[1] Denver Health and Hospital Authority,Rocky Mountain Poison and Drug Safety
[2] Washington University in St. Louis,Department of Psychiatry, School of Medicine
来源：
Clinical Drug Investigation | 2023年 / 43卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：197 / 203
页数：6
相关论文
共 38 条
  • [1] A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population
    Jewell, Jennifer
    Black, Joshua
    Ellis, Matthew
    Olsen, Heather
    Iwanicki, Janetta
    Dart, Richard
    CLINICAL DRUG INVESTIGATION, 2023, 43 (03) : 197 - 203
  • [2] Correction to: A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population
    Jennifer Jewell
    Joshua Black
    Matthew Ellis
    Heather Olsen
    Janetta Iwanicki
    Richard Dart
    Clinical Drug Investigation, 2023, 43 : 379 - 379
  • [3] A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population (vol 43, pg 197, 2023)
    Jewell, Jennifer
    Black, Joshua
    Ellis, Matthew
    Olsen, Heather
    Iwanicki, Janetta
    Dart, Richard
    CLINICAL DRUG INVESTIGATION, 2023, 43 (05) : 379 - 379
  • [4] Characterizing patients using abuse-deterrent formulations of extended-release opioid analgesics
    Oh, Gyeon
    DiPrete, Bethany
    Slavova, Svetla
    Dasgupta, Nabarun
    Ranapurwala, Shabbar I.
    Slade, Emily
    Delcher, Chris
    Moga, Daniela C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 165 - 166
  • [5] Abuse-deterrent extended-release oxycodone and risk of opioid-related harm
    Paljarvi, Tapio
    Strang, John
    Quinn, Patrick D.
    Luciano, Sierra
    Fazel, Seena
    ADDICTION, 2021, 116 (09) : 2409 - 2415
  • [6] Syringeability of morphine ARER, a novel, abuse-deterrent, extended-release morphine formulation
    Kinzler, Eric R.
    Pantaleon, Carmela
    Iverson, Matthew S.
    Aigner, Stefan
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2019, 45 (04): : 377 - 384
  • [7] Current and future development of extended-release, abuse-deterrent opioid formulations in the United States
    Webster, Lynn R.
    Markman, John
    Cone, Edward J.
    Niebler, Gwendolyn
    POSTGRADUATE MEDICINE, 2017, 129 (01) : 102 - 110
  • [8] Monitoring Internet postings for mentions of an extended-release hydrocodone formulation with abuse-deterrent properties
    DeVeaugh-Geiss, Angela
    Chilcoat, Howard
    Coplan, Paul
    Harikrishnan, Venkatesh
    Besharat, Andrea Carrig
    Green, Jody L.
    DRUG AND ALCOHOL DEPENDENCE, 2017, 171 : E54 - E54
  • [9] A Randomized, Crossover Study on the Effect of Food on the Pharmacokinetic Characteristics of Morphine ARER (MorphaBond™ ER), an Abuse-Deterrent Formulation of Extended-Release Morphine
    Kinzler, Eric R.
    Pantaleon, Carmela
    Iverson, Matthew
    Aigner, Stefan
    ADVANCES IN THERAPY, 2019, 36 (09) : 2394 - 2401
  • [10] A Randomized, Crossover Study on the Effect of Food on the Pharmacokinetic Characteristics of Morphine ARER (MorphaBond™ ER), an Abuse-Deterrent Formulation of Extended-Release Morphine
    Eric R. Kinzler
    Carmela Pantaleon
    Matthew Iverson
    Stefan Aigner
    Advances in Therapy, 2019, 36 : 2394 - 2401
1234